Avian ("Bird") Flu Stocks Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Avian ("Bird") Flu Stocks

NNVC 1.850

-2.6%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Allan Harris	10/26/2005 10:31:14 AM
	Read Replies (1) of 428

From September, 2005 Letter to Shareholders, CEO of Hemispherx Biopharma, Inc. (HEB): "We are also very exited about the developments relating to the oral form of our Alferon N product (Low Dose Oral Interferon Alfa-N3, Human Leukocyte Derived), which is a new delivery form of our FDA approved drug, Alferon N. Alferon N is the only natural interferon currently FDA approved and available in the marketplace. We were pleased to announce last quarter that clinical trials in human volunteers are being conducted in Philadelphia and that a clinical study will shortly commence at the Princess Margaret Hospital in Hong Kong. We are preparing more than 300,000 doses of Alferon LDO for appropriate clinical programs. Pending the outcome of the ongoing clinical studies and based on existing laboratory studies, we expect these trials to demonstrate that Alferon LDO given orally can activate the relevant immune defense pathways in the human body. This would potentially make Alferon LDO the first orally active interferon drug candidate and would open an opportunity leading to a wide range of potential new indications. "One such potential indication is Avian Flu. As widely covered in the media, Avian Flu is a devastating and contagious disease. Health officials are concerned that Avian Flu could mutate to a highly contagious form for humans. This scenario is considered by experts in the field as highly probable. Should this mutation occur it will be the genesis of the next pandemic and would render vaccines presently under development ineffective. The threat of a highly lethal pandemic has caused Governments around the world to search for a treatment that they could potentially stockpile." A

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next